What is ICH Q1A(R2) and what does it cover?

• A. It provides stability testing guidelines for drug substances and products, detailing long-term, intermediate, and accelerated conditions, as well as forced degradation to establish shelf-life and storage conditions.
• B. ICH Q1A(R2) outlines pharmacovigilance procedures for post-market surveillance.
• C. It describes packaging standards for primary containers.
• D. It establishes sterility testing protocols for injectables.

Answer: (B)

Stability testing guidelines outline how to evaluate how a drug substance and its final product hold up over time under different storage conditions. ICH Q1A(R2) specifies the testing regimes for long-term, intermediate, and accelerated storage, plus forced degradation under stress conditions to reveal degradation pathways and to confirm that the stability-indicating analytical methods can detect changes. The aim is to establish the product’s shelf-life and the appropriate storage conditions to maintain quality throughout its labeled period. This guideline does not cover pharmacovigilance after market, packaging standards, or sterility testing protocols, which are addressed by other topics.